Reduction in oral penicillamine absorption by food, antacid, and ferrous sulfate
- 1 April 1983
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 33 (4) , 465-470
- https://doi.org/10.1038/clpt.1983.63
Abstract
Plasma levels of penicillamine, urinary recovery of penicillamine and its oxidized metabolites, and urinary Cu excretion were examined after single 500-mg oral doses of penicillamine to 6 healthy men. Penicillamine was given after an overnight fast, a standard breakfast, an antacid and iron(II) sulfate. Following the fasting dose, the mean peak plasma level of 3.05 .mu.g/ml developed at 3.8 h and the drug was cleared from plasma with a t1/2 [half-life] of 2.1 h. Penicillamine levels were reduced to 52, 35 and 66% of those from the fasting dose after food, iron(II) sulfate and antacid. The rates of penicillamine appearance and disappearance from plasma were essentially treatment-independent. There were good correlations between urinary recovery of total penicillamine (r = 0.875), urinary Cu excretion (r = 0.758) and the penicillamine [area under the plasma concentration time curve]. The availability of oral penicillamine is very susceptible to interactions with other substances.This publication has 5 references indexed in Scilit:
- Bioavailability of Tolazamide from Tablets: Comparison of In Vitro and In Vivo ResultsJournal of Pharmaceutical Sciences, 1982
- Penicillamine kinetics in normal subjectsClinical Pharmacology & Therapeutics, 1981
- High-performance liquid chromatographic determination of penicillamine in whole blood, plasma, and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- The in vitro loss of penicillamine in plasma, albumin solutions, and whole blood: Implications for pharmacokinetic studies of penicillamineLife Sciences, 1980
- Determination of penicillamine in blood and urine by high performance liquid chromatographyAnalytical Chemistry, 1978